Autophagy suppresses breast cancer metastasis by degrading NBR1

Autophagy. 2020 Jun;16(6):1164-1165. doi: 10.1080/15548627.2020.1753001. Epub 2020 Apr 14.

Abstract

Macroautophagy/autophagy plays complex, context-dependent roles in cancer. How autophagy governs the emergence of metastatic disease has been incompletely understood. We recently uncovered that genetic autophagy inhibition strongly attenuates primary tumor growth in mammary cancer models, yet paradoxically promotes spontaneous metastasis to the lung and enables the outgrowth of disseminated tumor cells (DTCs) into overt macro-metastases. Furthermore, at both primary and metastatic sites, genetic autophagy inhibition leads to the marked expansion of tumor cells exhibiting aggressive and pro-metastatic basal epithelial differentiation. These pro-metastatic effects of autophagy inhibition are due to the cytosolic accumulation of the autophagy cargo receptor NBR1 in autophagy-deficient tumor cells.

Keywords: Autophagy; NBR1; TP63; chloroquine; keratin14; metastasis; rubicon.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Autophagy*
  • Breast Neoplasms*
  • Carrier Proteins
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Macroautophagy

Substances

  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • NBR1 protein, human